Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-11-01 Sale |
2021-11-03 7:38 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
50,000 | $15.03 | $751,500 | 705,090 (Indirect Direct) |
View |
2021-10-25 Sale |
2021-10-27 4:55 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
71,371 | $10.12 | $722,299 | 755,090 (Indirect Direct) |
View |
2021-10-21 Sale |
2021-10-22 7:58 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
1,898 | $9.01 | $17,101 | 826,461 (Indirect Direct) |
View |
2021-10-18 Sale |
2021-10-20 6:57 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
201,731 | $8.4152 | $1,697,614 | 828,359 (Indirect Direct) |
View |
2021-07-30 Sale |
2021-07-30 5:28 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
10,000 | $6.8072 | $68,072 | 1,136,090 (Indirect Direct) |
View |
2021-06-25 Sale |
2021-06-25 4:17 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
10,000 | $8.1345 | $81,345 | 1,146,090 (Indirect Direct) |
View |
2021-05-28 Sale |
2021-06-01 06:10 am |
Ocugen Inc. | OCGN | Kompella Uday Director |
7,191 | $8.819 | $63,417 | 1,030,090 (Indirect Direct) |
View |
2021-04-30 Sale |
2021-05-03 9:05 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
70,000 | $14.02 | $981,700 | 1,064,090 (Indirect Direct) |
View |
2021-04-26 Sale |
2021-04-28 6:52 pm |
Ocugen Inc. | OCGN | Kompella Uday Director |
350,000 | $11.7 | $4,095,000 | 1,080,090 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-28 Option Award |
2024-07-02 4:10 pm |
N/A 2034-06-28 |
Ocugen Inc. | OCGN | Kompella Uday Director |
66,929 | $0 | 66,929 (Direct) |
View |
2023-06-09 Option Award |
2023-06-09 5:27 pm |
N/A 2033-06-09 |
Ocugen Inc. | OCGN | Kompella Uday Director |
112,205 | $0 | 112,205 (Direct) |
View |
2022-06-07 Option Award |
2022-06-08 8:57 pm |
N/A 2032-06-07 |
Ocugen Inc. | OCGN | Kompella Uday Director |
140,091 | $0 | 140,091 (Direct) |
View |
2021-12-16 Option Award |
2021-12-17 9:22 pm |
N/A 2031-12-16 |
Ocugen Inc. | OCGN | Kompella Uday Director |
16,335 | $0 | 16,335 (Direct) |
View |
2021-07-30 Exercise |
2021-07-30 5:28 pm |
N/A 2031-01-01 |
Ocugen Inc. | OCGN | Kompella Uday Director |
10,000 | $0 | 1,136,090 (Direct) |
View |
2021-07-30 Exercise |
2021-07-30 5:28 pm |
N/A N/A |
Ocugen Inc. | OCGN | Kompella Uday Director |
10,000 | $1.83 | 1,136,090 (Direct) |
View |
2021-06-25 Exercise |
2021-06-25 4:17 pm |
N/A 2031-01-01 |
Ocugen Inc. | OCGN | Kompella Uday Director |
10,000 | $0 | 1,146,090 (Direct) |
View |
2021-06-25 Exercise |
2021-06-25 4:17 pm |
N/A N/A |
Ocugen Inc. | OCGN | Kompella Uday Director |
10,000 | $1.83 | 1,146,090 (Direct) |
View |
2021-05-28 Exercise |
2021-06-01 06:10 am |
N/A 2025-08-26 |
Ocugen Inc. | OCGN | Kompella Uday Director |
7,191 | $0 | 1,030,090 (Direct) |
View |
2021-05-28 Exercise |
2021-06-01 06:10 am |
N/A N/A |
Ocugen Inc. | OCGN | Kompella Uday Director |
7,191 | $1.88 | 1,030,090 (Direct) |
View |
2021-04-30 Exercise |
2021-05-03 9:05 pm |
N/A 2030-01-02 |
Ocugen Inc. | OCGN | Kompella Uday Director |
20,000 | $0 | 1,064,090 (Direct) |
View |
2021-04-30 Exercise |
2021-05-03 9:05 pm |
N/A N/A |
Ocugen Inc. | OCGN | Kompella Uday Director |
20,000 | $0.51 | 1,064,090 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 5:49 pm |
N/A 2031-01-01 |
Ocugen Inc. | OCGN | Kompella Uday Director |
126,000 | $0 | 126,000 (Direct) |
View |